Partner with Vacara to Advance Therapeutics in Autoimmunity and Beyond
Vacara AB collaborates with biotechnology companies, pharmaceutical organizations, and academic institutions to accelerate the development of next-generation immunotherapies and diagnostics.
Our proprietary humanized disease models and translational immunology platforms enable more predictive evaluation of immune-mediated diseases, improving decision-making from preclinical research to clinical development across autoimmunity, oncology, and inflammatory conditions.
Vacara supports programs from early discovery through translational development via flexible collaboration and licensing models, including research-use, option-to-license, and commercial agreements.
Flexible Collaboration Models
Vacara offers tailored partnership structures aligned to partner strategy and development stage:
Preclinical efficacy, mechanistic, and translational studies using Vacara’s humanized models. See our Service page for more information.
Access to Vacara’s proprietary models and technologies through flexible licensing and service-based collaboration structures tailored to your needs. Contact us to discuss further.
Strategic collaborations for therapeutics, vaccines, and translational programs. Contact us to discuss further.
Get Started
